Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Diagnostic accuracy of artificial intelligence-based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis.

Joseph S, Selvaraj J, Mani I, et al. Diagnostic accuracy of artificial intelligence-based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis. Am J Ophthalmol. 2024;263:214-230. doi:10.1016/j.ajo.2024.02.012.

Save
Print
June 26, 2024
Joseph S, Selvaraj J, Mani I, et al. Am J Ophthalmol. 2024;263:214-230.
View more articles from the same authors.

Artificial intelligence (AI) has been shown to have similar diagnostic accuracy to humans in mammography and other imaging studies. This review summarizes the accuracy of AI-based diabetic retinopathy (DR) screening from retinal images. Pooled analysis from 34 studies shows AI-based screening has acceptable performance for DR screening.

Save
Print
Cite
Citation

Joseph S, Selvaraj J, Mani I, et al. Diagnostic accuracy of artificial intelligence-based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis. Am J Ophthalmol. 2024;263:214-230. doi:10.1016/j.ajo.2024.02.012.